Advanced in vitro models of prostate cancer metastases: unravelling and overcoming ARSI resistance

This “allocated fund” was granted to Prof. Mark Rubin (University of Bern) in February 2022 for 2 years.

News & Events

Posted on

A study led by Professors Hanahan, Zeng, Saghafinia and Chryplewicz has uncovered a protein overexpressed in numerous cancer types that suppresses the…

Read more
Posted on

We were very honored to welcome Federal Councilor Guy Parmelin to our annual conference on the challenges in cancer research.

This event was a great…

Read more
Posted on

Congratulations to Prof. Elisa Oricchio – ISREC Foundation Chair in Translational Oncology from 2014 to 2020 – appointed Director of the ISREC…

Read more
Posted on

In recognition of her exceptional commitment to scientific research, Prof. Susan M. Gasser, director of the ISREC Foundation, received an honorary…

Read more